Company Snapshot
- Ticker
- BAX
- Name
- BAX
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 9385640000.000000
- Volume
- 6,907,599
- Avg Volume (3M)
- 7,389,163
BAX
BAX
Last update recent
18.26
+0.10
(+0.55%)
Market Cap
9385640000.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 11023000000.000000
- EPS
- -0.66
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 4.35%
- Net Income
- -341000000.000000
- Net Margin
- -3.09%
- Payout Ratio
- -119.65%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- -27.52
- Forward P/E
- None
- P/S
- 0.85
- P/B
- 1.30
- Beta
- None
- Debt / Equity
- 1.35
- Current Ratio
- 1.84
- Return on Equity
- -0.05%
- Return on Assets
- -0.02%
Technicals & Returns
- Distance vs 200 DMA
- -31.15%
- 200 DMA
- 26.52
- Distance vs 50 DMA
- -9.79%
- 50 DMA
- 20.24
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care products and pharmacy compounding services; parenteral nutrition therapies and related products; biological products and medical devices used in surgical procedures for hemostasis, tissue sealing and adhesio Read more
- Name
- BAX
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Jose E. Almeida
- Employees
- 60,000
- IPO Date
- 1981-10-27
- Phone
- 224 948 2000
- Address
- None
- Website
- https://www.baxter.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-08-30 • $0.29
Latest News
Curated headlines from premium sources.
Baxter International, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before December 15, 2025 to Discuss Your Rights – BAX
NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Baxter International, Inc. ("Baxter International, Inc." or the "Compan…
BAX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BAX
NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International …
BAXTER CLASS ACTION DEADLINE 12/15: Bragar Eagel & Squire, P.C. Reminds Baxter International Stockholders to Contact the Firm Regarding Their Rights
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Baxter (BAX) To Contact Him Directly To Discuss Th…
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)---- $BAX--BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm.
BAX Highlights EMR-Integrated Smart Pumps Boost Patient Safety & Care
Baxter shows EMR-integrated smart pumps cut safety alerts and speed IV setup, backed by real-world data from over a million infusions at ASHP 2025.
DEADLINE ALERT for MLTX, BAX, and JHX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, Dec. 15, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of share…